Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and Pituitary ACTH Hypersecretion

bromocriptine has been researched along with Pituitary ACTH Hypersecretion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benveniste, RJ; Delman, BN; King, WA; Lee, JS; Post, KD; Walsh, J1
Hirata, Y; Kawamura, M; Miki, H; Miyazaki, S; Nakano, T; Tamura, Y1

Other Studies

2 other study(ies) available for bromocriptine and Pituitary ACTH Hypersecretion

ArticleYear
Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma.
    Journal of neurosurgery, 2005, Volume: 102, Issue:6

    Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Child; Combined Modality Therapy; Female; Hormone Antagonists; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Neurosurgical Procedures; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Postoperative Complications; Predictive Value of Tests; Radiotherapy; Reoperation; Retrospective Studies; Sphenoid Bone; Treatment Outcome

2005
Bromocriptine-responsive Cushing's disease; clinical and biochemical remission accompanied by amelioration of impaired ocular movement.
    Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:14

    Topics: Adenoma; Aged; Bromocriptine; Female; Hormone Antagonists; Humans; Ocular Motility Disorders; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Remission Induction; Treatment Outcome

2007